JB Labs

JB Pharma (J.B. Chemicals & Pharmaceuticals Limited) is a leading Indian pharmaceutical company specializing in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company is particularly well-known for its strong presence in the gastrointestinal, cardiovascular, and anti-infective therapeutic areas, with flagship brands like Rantac (ranitidine), Cilacar (cilnidipine), and Metrogyl (metronidazole). Following a majority stake acquisition by KKR in 2020, the company has undergone a strategic rebranding to "JB Pharma" and is expanding its portfolio into high-growth segments such as nephrology, respiratory, and dermatology. JB Pharma operates multiple state-of-the-art manufacturing facilities and exports its products to over 40 countries, including regulated markets like the US and Europe.